Analysis
Filter results by
Search HelpCurrently selected filters that can be removed
Keyword(s)
Author(s)
4 facets displayed. 0 facets selected.
Survey or statistical program
1 facets displayed. 1 facets selected.
Results
All (3)
All (3) ((3 results))
- Articles and reports: 41-20-00022024003Description: The paper presents analysis using data from the Survey on Access to Health Care and Pharmaceuticals during the Pandemic (SAHCPDP) to examine prevalence of prescription insurance, the impact of the pandemic on prescription insurance coverage, medication use, the relationship between appointment scheduling issues and inability to obtain new prescriptions, out-of-pocket medication spending, and the relationship between prescription insurance coverage and medication non-adherence due to cost among First Nations people living off reserve, Métis and Inuit in the provinces.Release date: 2024-10-15
- Articles and reports: 75-006-X202200100011Description: This study examines Canadians’ access to and use of pharmaceuticals using data from the 2021 Survey on Access to Health Care and Pharmaceuticals During the Pandemic, collected from March to May 2021. First, it examines the proportion and characteristics of Canadians who reported not having prescription insurance to cover medication costs, as well as those who reported that their prescription insurance was affected by the pandemic. Next, medication use, out-of-pocket spending on prescription medication, and non-adherence to prescription medication because of cost were examined. Analyses are presented across province, immigration status, and racialized groups, among other sociodemographic variables, and thus offers insight into potential inequities in access to pharmaceuticals in Canada.Release date: 2022-11-02
- 3. Pharmaceutical access and use ArchivedStats in brief: 11-627-M2022071Description: Based on data from the 2021 Survey on Access to Health Care and Pharmaceuticals During the Pandemic, this infographic examines pharmaceutical access and use across regions and immigration status. It also looks out-of-pocket spending on medication and non-adherence to prescription medication because of cost.Release date: 2022-11-02
Stats in brief (1)
Stats in brief (1) ((1 result))
- 1. Pharmaceutical access and use ArchivedStats in brief: 11-627-M2022071Description: Based on data from the 2021 Survey on Access to Health Care and Pharmaceuticals During the Pandemic, this infographic examines pharmaceutical access and use across regions and immigration status. It also looks out-of-pocket spending on medication and non-adherence to prescription medication because of cost.Release date: 2022-11-02
Articles and reports (2)
Articles and reports (2) ((2 results))
- Articles and reports: 41-20-00022024003Description: The paper presents analysis using data from the Survey on Access to Health Care and Pharmaceuticals during the Pandemic (SAHCPDP) to examine prevalence of prescription insurance, the impact of the pandemic on prescription insurance coverage, medication use, the relationship between appointment scheduling issues and inability to obtain new prescriptions, out-of-pocket medication spending, and the relationship between prescription insurance coverage and medication non-adherence due to cost among First Nations people living off reserve, Métis and Inuit in the provinces.Release date: 2024-10-15
- Articles and reports: 75-006-X202200100011Description: This study examines Canadians’ access to and use of pharmaceuticals using data from the 2021 Survey on Access to Health Care and Pharmaceuticals During the Pandemic, collected from March to May 2021. First, it examines the proportion and characteristics of Canadians who reported not having prescription insurance to cover medication costs, as well as those who reported that their prescription insurance was affected by the pandemic. Next, medication use, out-of-pocket spending on prescription medication, and non-adherence to prescription medication because of cost were examined. Analyses are presented across province, immigration status, and racialized groups, among other sociodemographic variables, and thus offers insight into potential inequities in access to pharmaceuticals in Canada.Release date: 2022-11-02